PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: business
Mass Gift Ban Repeal Efforts Fizzle
An effort in the Massachusetts legislature to repeal the state’s ban on many gifts to healthcare providers has failed. The year-old ban is considered one of the most restrictive in the country, banning restaurant meals, various gifts and requiring reporting on transfers of value above $50.
“This repeal effort was started by legislators concerned that the [...]
Posted in Legal Also tagged Food and Drug Administration, Health care, health insurance, Law, Massachusetts, Prescription drug, United States 1 Comment
Study: Future of Personalized Medicine
An increased focus on targeted medicine has become a staple for all facets of healthcare, from drug developers to consumers to pharma companies. Gerson Lehrman and Bloomberg jointly commissioned a survey that gauged the reactions and predictions of this trend from 52 leading US physicians. The survey covered a number of topics to assess which [...]
Posted in R&D Also tagged Biotechnology and Pharmaceuticals, Health, Health care, Medicine, Personalized medicine, Physician, Research and development 1 Comment
Merck to Close Eight Plants
Image by Getty Images via @daylife
Over the next two years, Merck will shut down eight manufacturing plants, as well as eight research sites, as part of the ongoing Schering-Plough merger process. The company said in a statement that the various site exits will help “create a flexible R&D organization.”
Taking a page out of Pfizer’s book [...]
Posted in Strategy Also tagged Canada, Factory, Infectious disease, Merck, Research and development, Schering Plough, South America 3 Comments
GSK Scores High in Market Access
GlaxoSmithKline ranked number one in a study of pharmaceutical companies offering access to medicines to emerging and developing nations, proving that the UK drug giant has a far stronger grasp on new markets than its US and Japanese counterparts.
The study ranks 20 companies based on significant criteria including pricing, patents and intellectual properties, capacity enhancement, [...]
Pipeline Report Preview